AGI-1095

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAGI-1095
Drug Alias NameAGI-1095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL cholesterol enhancers
TargetsUpdating
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAtherogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtherogenics Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A